|
|
 |
|
IMMU: Immunomedics Inc - Stock News |
Enter Ticker:
|
|
| Nov 19, 2009 |
Complimentary Research Report on PETM, IMMU, RINO, AMSC, EXPE andBNVI by WallStSense.com |
| Nov 17, 2009 |
Immunomedics Down 22.1% Since SmarTrend's Sell Recommendation |
| Nov 09, 2009 |
Immunomedics Down 21.4% Since SmarTrend's Sell Recommendation |
| Nov 06, 2009 |
Immunomedics Announces First Quarter Fiscal 2010 Results and Clinical Program Developments |
| Nov 02, 2009 |
Immunomedics Down 25.3% Since SmarTrend's Sell Recommendation |
| Oct 29, 2009 |
TheFortuneFinancial.com Free Market Research on AMKR, EXPE, IMMU,BNVI, UCBH and FLIR |
| Oct 27, 2009 |
Immunomedics Down 19.4% Since SmarTrend's Sell Recommendation |
| Oct 27, 2009 |
Immunomedics to Present at Upcoming Conferences |
| Oct 23, 2009 |
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 23, 2009 : IMMU, ANCI, SLTC and PCLN |
| Oct 23, 2009 |
Immunomedics Receives Corporate Award From New Jersey Inventors Hall of Fame |
| Oct 21, 2009 |
NIH Awards 3 Grants To Immunomedics |
| Oct 20, 2009 |
Immunomedics Down 5.8% Since SmarTrend's Sell Recommendation |
| Oct 19, 2009 |
Immunomedics Awarded Three Grants by NIH to Develop New Agents for Imaging and Therapy of Cancer |
| Oct 16, 2009 |
Immunomedics reports further topline results from Phase IIb lupus trial |
| Oct 15, 2009 |
Further Topline Results for Epratuzumab Phase IIb Study in Systemic Lupus Erythematosus (SLE) |
| |
| ZACKS COMMENTARY FOR IMMU |
|
|
|
Sponsored Links 
0.00